Skip to main content

Healthcare- and pharma-economic models in support of the International Consortium for Personalised Medicine

Deliverables

Guidance paper on health economic modelling of per-sonalised medicine

Guidance paper on health economic modelling of per-sonalised medicine

Checklist methodological quality

Checklist to assess the methodological quality of model-based economic evaluations of personalised medicine

Overview of major findings from interviews

Overview of major findings from interviews

Workshop 1 report

Workshop 1 report

Searching for OpenAIRE data...

Publications

POSB75 What is the Net Added Value of Personalised Medicine? A Systematic Literature Review

Author(s): Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Isaac Corro-Ramos, László Szilberhorn, Tamás Zelei, Balázs Nagy, Rositsa Koleva-Kolarova, Apostolos Tsiachristas, Sarah Wordsworth, Maureen Rutten-van Mölken
Published in: Value in Health, 2022
Publisher: ISPOR
DOI: 10.1016/j.jval.2021.11.348

105P Prognostic value of the NTRK fusion biomarker in the Netherlands

Author(s): Irene Santi, Heleen Vellekoop, Simone Huygens, Maureen Rutten-van Mölken, Matthijs Versteegh
Published in: Annals of Oncology, 2021, ISSN 1569-8041
Publisher: Elsevier
DOI: 10.1016/j.annonc.2021.08.385

Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2,022 UK patients

Author(s): Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Published in: BMC Cancer (SUBMITTED), 2023
Publisher: Springer

Financing and reimbursement models for personalised medicine: a review to identify current models and future options

Author(s): Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Published in: Applied Health Economics and Health Policy (ACCEPTED), 2022
Publisher: Springer

RE1 Financing and Reimbursement for Personalised Medicine - Are WE There YET?

Author(s): Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten-van Molken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth, Apostolos Tsiachristas
Published in: Value in Health, 2020
Publisher: ISPOR
DOI: 10.1016/j.jval.2020.08.2071

Systematic review of financing and reimbursement models for personalised medicine.

Author(s): Rositsa Koleva-Kolarova, Apostolos Tsiachristas, James Buchanan, Sarah Wordsworth
Published in: PROSPERO 2019 CRD42019146764, n/a, 2020, Page(s) n/a
Publisher: PROSPERO